Blog

2020 – a watershed year for EpiGuard

2020 has been a truly unique and challenging year by any standard, and healthcare systems worldwide have been put to an extreme test. Among the many lessons learned, has been the need for better preparedness, procedures, training, and equipment for transporting infectious patients to the designated area for treatment and care.

The global pandemics surprised us all and presented many challenges – not the least of which were disrupted supply chain, travel restrictions, and home office. But the EpiGuard team rose to the challenge with hard work, creativity, and resilience. To conclude this extraordinary year of 2020, let us start from the beginning.

WHAT

EpiGuard AS is an innovative Norwegian medical technology company established in 2015 by a group of doctors at the Oslo University Hospital with safe transport of contagious patients as our main aim.

WHY

In March 2014 there was an Ebola outbreak in Western Africa, and a Norwegian doctor working in the area contracted the disease. The medical team responsible for her transport home found that existing isolation systems did not provide the necessary protection or treatment options.

26

In addition to dedicated sales resources in Norway, France, and the UK and Ireland, EpiGuard has a network of excellent distributors in 26 countries, covering a population of over 1 billion people.


3x

Over the course of 2020, EpiGuard has almost trebled the number of employees, ranging form sales and marketing, to logistics and manufacturing!

2,495,000

In May 2019, EpiGuard received a EUR 2.495.000 grant from the European Union’s Horizon 2020 Research and Innovation programme.


200+

With more than 200 EpiShuttles dispatched throughout the world, the learning process of our medical and technical experts didn’t stop. With every challenge there is an opportunity to be explored and the team is constantly looking for ways to further develop and improve our products, processes and services.

“In 2020, the EpiShuttle became the gold standard for transport of patients with highly infectious diseases.”

Ellen Catherine Andersen
CEO

“With excellent reference customers and a large installed base of EpiShuttle units in operation, EpiGuard look forward to continued growth in 2021.”

Michael Eimstad
VP Sales & Marketing
What the future holds?

EpiGuard has big plans ahead for the future. In 2021 we are planning new product launches, hiring more excellent people, and will continue our geographical expansion into new markets. Stay tuned for more information!

There is more good news coming in 2021. Subscribe to our newsletter and be the first one to know!

Copyright 2019 @ EpiGuard